Atlas Trials

Study of ORL-1M (D-mannose) in Patients With CDG-Ib

Clinical trial NCT03404869 · UNKNOWN

Trial details

NCT number
NCT03404869
Sponsor
Orpha Labs
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
CDG Ib
Start date
2015-03-31
Primary completion
2019-06-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.